Patricia L. Judson, MD
Senior Vice President, Medical Strategy
Patricia Judson joined Karyopharm in February 2022 and is responsible for key medical strategic decisions and insights for the organization.
Dr. Judson brings more than 25 years of oncology experience to her new role. Prior to joining Karyopharm, she served as Vice President and Global Head of Women’s Oncology, Medical Affairs at GSK. Previously, Dr. Judson served as the U.S. Medical Head for the DNA Damage Response Franchise in Women’s Oncology at AstraZeneca. She began her career as an academic gynecologic oncologist and is a peer-recognized scientist with experience in translational cancer research, as well as clinical trial design and management.
Dr. Judson completed her M.D. at the University of Minnesota School of Medicine, Residency in Obstetrics & Gynecology at the University of California, San Francisco, and her Fellowship in Gynecologic Oncology at the University of North Carolina at Chapel Hill.